Omnicell | OMCL - Cash And Equivalent


Omnicell reported $239.22M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
AppLovin 2.76B 271.58M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Cardinal Health USD 3.94B 1.16B Mar/2026
Cerillion plc GBP 23.64M 1.09M Dec/2023
Healthcare Services USD 136.17M 10.98M Mar/2026
HealthStream USD 48.71M 12.55M Mar/2026
HeartBeam USD 2.04M 2.34M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
McKesson USD 3.98B 1.02B Mar/2026
Nebius Group 9.3B 5.62B Mar/2026
Omnicell USD 239.22M 42.7M Mar/2026
Stanley Black & Decker USD 333.7M 53.6M Mar/2026
Steris USD 423.7M 104.5M Dec/2025
Trubridge Inc USD 24.85M 4.93M Dec/2025
Veeva Systems USD 1.9B 475.35M Mar/2026
Veradigm USD 492.6M 7.57M Sep/2022